ReviewThe Journal of international medical research2020
Primary hepatic neuroendocrine tumor with multiple liver metastases: A case report with literature review.
Review in The Journal of international medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 15 citations in OpenAlex.
- Primary giant hepatic neuroendocrine neoplasms in a young adult: case report and literature review.Frontiers in oncology · 2025Article
- Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy.Annals of surgical oncology · 2024Article
- Imaging findings in malignant hepatic infiltration from neuroendocrine tumor presenting with acute liver failure and mimicking cirrhosis: a case description.Quantitative imaging in medicine and surgery · 2024Article
- Primary hepatic functional neuroendocrine tumor in an elderly female: Case report.Clinical case reports · 2024Article
- A rare primary hepatic neuroendocrine tumour with laparoscopic resection: a case report.Journal of medical case reports · 2023Article
- Case Report: Primary hepatic neuroendocrine tumor: two cases report with literature review.Frontiers in oncology · 2023Article
- Article
- Case Report: A rare case of primary paraganglioma of the gallbladder with a literature review.Frontiers in oncology · 2022Article
- Primary Neuroendocrine Tumor of the Liver With Papillary Features in a Multivisceral Transplant Patient.Cureus · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary hepatic neuroendocrine tumors (PHNETs) are a group of extremely rare tumors that are difficult to differentiate from common hepatic malignancies on routine imaging studies. By presenting a case of PHNET, we herein introduce our experience with the diagnosis, differential diagnosis, and management of patients with this rare disease. The patient was preoperatively diagnosed with hepatic hydatidosis but postoperatively diagnosed with a PHNET with multiple liver metastases. He was successfully treated with transcatheter arterial chemoembolization. This case indicates that the clinical diagnosis of PHNET is a medical challenge. Although peptide receptor radionuclide therapy has been suggested as the mainstay of treatment for well-differentiated somatostatin receptor-positive PHNETs, patients with a large tumor burden may also benefit from transcatheter arterial chemoembolization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.